Muscle impairments; muscle function; quality of life assessment; sarcopenia; specific questionnaire
Abstract :
[en] INTRODUCTION:
Sarcopenia, defined by a progressive and generalized loss of muscle mass and muscle function, is associated with many harmful clinical consequences. Several studies have reported the impact of sarcopenia on health-related quality of life (HRQoL) using generic quality of life (QoL) questionnaires. The results of these observational studies are quite heterogenous. Indeed, generic tools may not be able to detect subtle effects of sarcopenia on QoL. Recently, a sarcopenia-specific HRQoL questionnaire was developed and validated in a population of sarcopenic subjects to more accurately assess the impact of sarcopenia on QoL. Areas covered: The purpose of this review is to present evidence regarding the impact of sarcopenia on QoL and to introduce a new specific HRQoL questionnaire, the SarQoL®. Expert commentary: The self-administered SarQoL®, initially developed in French, comprises 55 items translated into 22 questions. The questionnaire has been shown to be understandable, valid, consistent, and reliable and can therefore be recommended for clinical and research purposes. The questionnaire is now available in 11 different languages with another 20 translations in progress. The instrument's sensitivity to change still needs to be assessed in future longitudinal studies.
Disciplines :
Public health, health care sciences & services Geriatrics
Author, co-author :
Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Geerinck, Anton ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Locquet, Médéa ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia
Publication date :
2017
Journal title :
Expert Review of Pharmacoeconomics and Outcomes Research
Deschenes MR., Effects of aging on muscle fibre type and size. Sports Med. 2004;34:809–824.
Rosenberg IH., Sarcopenia:origins and clinical relevance. J Nutr. 1997 May 01;127:990S–991S.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Apr 16;39:412–423.
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia:an undiagnosed condition in older adults. Current consensus definition:prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011 Apr 30;12:249–256.
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project:rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–558.
Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility:an international consensus. J Am Med Dir Assoc. 2011;12:403–409.
Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia:joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29:154–159.
Dam -T-T, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69:584–590.
Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia:definitions and outcome parameters. Osteoporos Int. 2012 Feb 01;23:1839–1848.
Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults:a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014 Sep 23;43:748–759.
Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world:a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.
Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia:a systematic review and meta-analysis. PLoS One. 2017;12:e0169548. Wright JM, editor.
Beaudart C, Rizzoli R, Bruyère O, et al. Sarcopenia:burden and challenges for public health. Arch Public Heal BioMed Central Ltd. 2014;72:45.• Burden of sarcopenia for public health.
Cao L, Morley JE, Rosenberg H, et al. Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17:675–677.• Sarcopenia is recognized as an independent condition.
Rizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013 Jul 06;93:101–120.• Review paper on quality of life in sarcopenia.
Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun 11;30:473–483.
Rabin R, De Charro F. EQ-5D:a measure of health status from the EuroQol Group. Ann Med. 2001 Aug 09;33:337–343.
Brooks R. EuroQol:the current state of play. Health Policy (New York). 1996 Jun 06;37:53–72.
Silva Neto LS, Karnikowiski MG, Tavares AB, et al. Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev Bras Fisioter. 2012 Sep 18;16:360–367.
Sayer AA, Syddall HE, Martin HJ, et al. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing. 2006 May 13;35:409–415.
Chan OYA, Van Houwelingen AH, Gussekloo J, et al. Comparison of quadriceps strength and handgrip strength in their association with health outcomes in older adults in primary care. Age (Dordr). 2014;36:9714.
Gariballa S, Alessa A. Association between muscle function, cognitive state, depression symptoms and quality of life of older people:evidence from clinical practice. Aging Clin Exp Res. 2017.
Bekfani T, Pellicori P, Morris DA, et al. Sarcopenia in patients with heart failure with preserved ejection fraction:impact on muscle strength, exercise capacity and quality of life. Int J Cardiol. 2016;222:41–46.
Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002 Nov 29;57:M772–7.
Sexton E, King-Kallimanis BL, Conroy RM, et al. Psychometric evaluation of the CASP-19 quality of life scale in an older Irish cohort. Qual Life Res. 2013;22:2549–2559.
Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia:the SarcoPhAge study. Exp Gerontol. 2015;69:103–110.
Go SW, Cha YH, Lee JA, et al. Association between Sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med. 2013;34:281–288.
Koo H-K, Park J-H, Park HK, et al. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease:Korean national health and nutrition examination survey. PLoS One. 2014;9:e110448. Cappello F, editor.
Manrique-Espinoza B, Salinas-Rodríguez A, Rosas-Carrasco O, et al. Sarcopenia is associated with physical and mental components of health-related quality of life in older adults. J Am Med Dir Assoc. 2017;18:636.e1-636.e5.
Messier V, Karelis AD, Lavoie M-E, et al. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women:a MONET study. Appl Physiol Nutr Metab [Physiol Appl Nutr Métabolisme]. 2009;34:18–24.
Morishita S, Kaida K, Tanaka T, et al. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012 Apr 25;20:3161–3168.
Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008 Aug 12;56:1710–1715.
Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition:findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013 Feb 07;42:378–384.
Pedrero-Chamizo R, G?mez-Cabello A, M?Lendez A, et al. Higher levels of physical fitness are associated with a reduced risk of suffering sarcopenic obesity and better perceived health among the elderly. The EXERNET multi-center study. J Nutr Health Aging. 2015;19:211–217.
Gomez-Cabello A, Pedrero-Chamizo R, Olivares PR, et al. Prevalence of overweight and obesity in non-institutionalized people aged 65 or over from Spain:the elderly EXERNET multi-centre study. Obes Rev. 2011;12:583–592.
Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 Apr 29;147:755–763.• First operational definition of sarcopenia.
Wu T-Y, Liaw C-K, Chen F-C, et al. Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality. J Am Med Dir Assoc. 2016;17:1129–1135.
Malmstrom TK, Morley JE. SARC-F:a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531–532.
Yadav A, Chang Y-H, Carpenter S, et al. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015;29:134–141.
Beaudart C, Biver E, Reginster J-Y, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects:the SarQoL. Age Ageing. 2015;44:960–966.•• Development of the original SarQoL® questionnaire.
Beaudart C, Biver E, Reginster J-Y, et al. Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):238-244.•• Validation of the original SarQoL® questionnaire.
Johnson C, Aaronson NK, Blazeby JM, et al. EORTS quality of life group:guidelines for developing questionnaire modules. Eur Organ Res Treat Cancer. 2011. 4th ed. Available from:http://groups.eortc.be/qol/sites/default/files/archives/guidelines_for_developing_questionnaire-_final.pdf
Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Cmaj. 1986 Apr;15(134):889–895.
Beaudart C, Edwards MH, Moss C, et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing. 2016;0:1–7.
Nglazi MD, West SJ, Dave JA, et al. Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa. BMC Public Health. 2014;14:676.
Zhou J, Ru X, Hearst N, et al. Individual and household-level predictors of health related quality of life among middle-aged people in rural Mid-east China:a cross-sectional study. BMC Public Health. 2014;14:660.
Dupuy C, Lauwers-Cances V, Guyonnet S, et al. Searching for a relevant definition of sarcopenia:results from the cross-sectional EPIDOS study. J Cachexia Sarcopenia Muscle. 2015;6:144–154.
Bijlsma AY, Meskers MC, Molendijk M, et al. Diagnostic measures for sarcopenia and bone mineral density. Osteoporos Int. 2013 May 08;24:2681–2691.
Beaudart C, Reginster JY, Slomian J, et al. Prevalence of sarcopenia:the impact of different diagnostic cut-off limits. J Musculoskelet Neuronal Interact. 2014;14:425–431.
Beaudart C, Reginster JY, Slomian J, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol. 2014 Dec 03;61C:31–37.
Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007 May 12;55:769–774.
